drugset / Trial / NCT03640624

Multidisciplinary Treatment of Chronic Vulvar Pain

NCT03640624 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

Vulvodynia (i.e. chronic vulvar pain without identifiable cause) is a heterogeneous clinical entity with a complex multifactorial causation. It is long lasting and difficult to treat, and the general consensus of current guidelines states that patients with vulvodynia benefit from a compound multidisciplinary intervention targeting mucosal hypersensitivity, pelvic muscle floor dysfunction and general pain management. However, there is little empiric evidence to support this recommendation. This will be a randomized controlled trial comparing multidisciplinary treatment with standard care for women with vulvodynia.

Timeline

Start
2018-09-18
Primary completion
2024-11-10
Completion
2027-06

Drugs

EvaluationDrugModalityDoseRoute
Background Lidocaine Other / unclassified 5 % Topical